Stability of bortezomib 1-mg/mL solution in plastic syringe and glass vial

Annals of Pharmacotherapy

Volumn 39, Issue 9, 2005, Pages 1462-1466

  André, Pascal ^a   Cisternino, Salvatore ^a   Chiadmi, Fouad ^a   Toledano, Audrey ^a   Schlatter, Joël ^a   Fain, Olivier ^a   Fontan, Jean Eudes ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

Bortezomib; Stability

Indexed keywords

ANTINEOPLASTIC AGENT; BORTEZOMIB; GLASS; PLASTIC; PROTEASOME INHIBITOR; SODIUM CHLORIDE;

ARTICLE; DARKNESS; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT; OXIDATION; PH; PRECIPITATION; PRIORITY JOURNAL; STORAGE TEMPERATURE; SYRINGE; VALIDATION PROCESS;

ANTINEOPLASTIC AGENTS; BORONIC ACIDS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; GLASS; PHARMACEUTICAL SOLUTIONS; PLASTICS; PYRAZINES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SYRINGES; TEMPERATURE;

EID: 23944476075     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E620     Document Type: Article

References (10)

1. Richardson PG, Hideshima T, Mitsiades C, Anderson K. Proteasome inhibition in hematologic malignancies. Ann Med 2004;36:304-14.
2. Paramore A, Frantz S. Bortezomib. Nat Rev Drug Discov 2003;2:611-2.
3. Adams J. The development of proteasome inhibitors as anticancer drugs. Cancer Cell 2004;5:417-21.
4. Adams J. Proteasome inhibitors as new anticancer drugs. Curr Opin Oncol 2002;14:628-34.
5. Papandreou CN, Logothetis CJ. Bortezomib as a potential treatment for prostate cancer. Cancer Res 2004;64:5036-43.
6. Amiri KI, Horton LW, LaFleur BJ, Sosman JA, Richmond A. Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma. Cancer Res 2004;64: 4912-8.
7. O'Connor OA. The emerging role of bortezomib in the treatment of indolent non-Hodgkin's and mantle cell lymphomas. Curr Treat Options Oncol 2004;5:269-81.
8. Product information. Velcade (bortezomib). Issy les Moulineaux, France: Janssen-Cilag Velcade, France, May 2004.
9. Millennium Pharmaceuticals. Velcade: scientific discussion, European Medicines Agency. www.emea.eu.int/humandocs/Humans/EPAR/velcade/ velcade.htm (accessed 2005 Jan 21).
10. Torssell K. The chemistry of boronic and borinic acids. In: Steinberg H, McCloskey AL, eds. Progress in boron chemistry. US: Pergamon Press, 1964:369-415.